The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bates, M. E.
Right arrow Articles by Busse, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bates, M. E.
Right arrow Articles by Busse, W. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*12-O-TETRADECANOYLPHORBOL-13-ACETATE

The Journal of Immunology, Vol 156, Issue 2 711-718, Copyright © 1996 by American Association of Immunologists


ARTICLES

IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils

ME Bates, PJ Bertics and WW Busse
Department of Medicine, University of Wisconsin, Madison 53792, USA.

IL-5 is a member of the hemopoietic cytokine family and has profound effects on the differentiation, survival, migration, and effector function of human eosinophils. Increased tyrosine phosphorylation has been observed as an early event in IL-5 signal transduction in eosinophils; most notably, proteins of 45 and 135 kDa became tyrosine phosphorylated following IL-5 treatment. Some of these phosphotyrosine- containing proteins may represent intermediates in IL-5 signal transduction pathways. This study demonstrates that Jak-2, a tyrosine kinase, is increasingly tyrosine phosphorylated after IL-5 treatment of human eosinophils. Furthermore, we found proteins of 42, 44, and 45 kDa immunoreactive with anti-mitogen-activated protein (MAP) kinase Abs that are expressed in human eosinophils. One of these, the protein of approximately 45 kDa (p45), was tyrosine phosphorylated following treatment of eosinophils with IL-5 and PMA, as seen by anti- phosphotyrosine immunoprecipitation and immunoblotting with anti-MAP kinase Abs. In addition, anti-phosphotyrosine immunoprecipitates of IL- 5-treated eosinophils contained enhanced phosphotransferase activity toward a myelin basic protein (MBP) peptide substrate when compared with control-treated eosinophils. In contrast to cytokine-stimulated MAP kinase activation in other cells, there is no evidence of tyrosine phosphorylation or enzymatic activation of p42 MAP kinase in eosinophils after IL-5 treatment. These data suggest that Jak-2 kinase and an activated isoform of MAP kinase, p45, are detected following incubation with IL-5, and may mediate some of this cytokine's effects on eosinophils in a manner unique to the activation pathways previously described for other cells.


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. K. Wong, W. K. Ip, and C. W. K. Lam
Interleukin-3, -5, and Granulocyte Macrophage Colony-Stimulating Factor-Induced Adhesion Molecule Expression on Eosinophils by p38 Mitogen-Activated Protein Kinase and Nuclear Factor-{kappa}B
Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 133 - 147.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Esnault and J. S. Malter
Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-alpha plus fibronectin-activated peripheral blood eosinophils
Blood, May 13, 2002; 99(11): 4048 - 4052.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. R. Crosby, H. H. Shen, M. T. Borchers, J. P. Justice, T. Ansay, J. J. Lee, and N. A. Lee
Ectopic expression of IL-5 identifies an additional CD4+ T cell mechanism of airway eosinophil recruitment
Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L99 - L108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Temple, E. Allen, J. Fordham, S. Phipps, H.-C. Schneider, K. Lindauer, I. Hayes, J. Lockey, K. Pollock, and R. Jupp
Microarray Analysis of Eosinophils Reveals a Number of Candidate Survival and Apoptosis Genes
Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 425 - 433.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. J. Hall, J. Cui, M. E. Bates, B. A. Stout, L. Koenderman, P. J. Coffer, and P. J. Bertics
Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability
Blood, October 1, 2001; 98(7): 2014 - 2021.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Bhattacharya, B. A. Stout, M. E. Bates, P. J. Bertics, and J. S. Malter
Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-5 Activate STAT5 and Induce CIS1 mRNA in Human Peripheral Blood Eosinophils
Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 312 - 316.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H.-M. Huang, C.-J. Huang, and J. J.-Y. Yen
Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways
Blood, September 1, 2000; 96(5): 1764 - 1771.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Bates, V. L. Green, and P. J. Bertics
ERK1 and ERK2 Activation by Chemotactic Factors in Human Eosinophils Is Interleukin 5-dependent and Contributes to Leukotriene C4 Biosynthesis
J. Biol. Chem., April 6, 2000; 275(15): 10968 - 10975.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Kankaanranta, P. M. De Souza, P. J. Barnes, M. Salmon, M. A. Giembycz, and M. A. Lindsay
SB 203580, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances Constitutive Apoptosis of Cytokine-Deprived Human Eosinophils
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 621 - 628.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Adachi and R. Alam
The mechanism of IL-5 signal transduction
Am J Physiol Cell Physiol, September 1, 1998; 275(3): C623 - C633.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Cortegano, V. del Pozo, B. Cardaba, B. de Andres, S. Gallardo, A. del Amo, I. Arrieta, A. Jurado, P. Palomino, F.-T. Liu, et al.
Galectin-3 Down-Regulates IL-5 Gene Expression on Different Cell Types
J. Immunol., July 1, 1998; 161(1): 385 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Wang, P. Wu, B. Cheewatrakoolpong, J. G. Myers, R. W. Egan, and M. M. Billah
Selective Inhibition of IL-5 Receptor {alpha}-Chain Gene Transcription by IL-5, IL-3, and Granulocyte-Macrophage Colony-Stimulating Factor in Human Blood Eosinophils
J. Immunol., May 1, 1998; 160(9): 4427 - 4432.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Ogata, T. Kouro, A. Yamada, M. Koike, N. Hanai, T. Ishikawa, and K. Takatsu
JAK2 and JAK1 Constitutively Associate With an Interleukin-5 (IL-5) Receptor alpha  and beta c Subunit, Respectively, and Are Activated Upon IL-5 Stimulation
Blood, April 1, 1998; 91(7): 2264 - 2271.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Coffer, R. C. Schweizer, G. R. Dubois, T. Maikoe, J.-W. J. Lammers, and L. Koenderman
Analysis of Signal Transduction Pathways in Human Eosinophils Activated by Chemoattractants and the T-Helper 2-Derived Cytokines Interleukin-4 and Interleukin-5
Blood, April 1, 1998; 91(7): 2547 - 2557.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. E. Bates, W. W. Busse, and P. J. Bertics
Interleukin 5 Signals through Shc and Grb2 in Human Eosinophils
Am. J. Respir. Cell Mol. Biol., January 1, 1998; 18(1): 75 - 83.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. Horiuchi and P. F. Weller
Expression of Vascular Endothelial Growth Factor by Human Eosinophils: Upregulation by Granulocyte Macrophage Colony-stimulating Factor and Interleukin-5
Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 70 - 77.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.